Cargando…
Blockage of the IL-31 Pathway as a Potential Target Therapy for Atopic Dermatitis
Atopic dermatitis (AD), a pruritic, inflammatory chronic disease with multifactorial pathogenesis, has been a therapeutic challenge. Novel target treatments aim to reduce not only the immunologic dysfunction and microbiome dysbiosis but also the recovery of the damaged skin barrier. The current revi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961325/ https://www.ncbi.nlm.nih.gov/pubmed/36839897 http://dx.doi.org/10.3390/pharmaceutics15020577 |